04 Jun 2024
Mumtalakat and M42 announce Amana Healthcare Bahrain expansion

M42’s cutting-edge Microbiome Wellness Program is a game-changer for gut health

  • The program consists of two key elements: a comprehensive microbiome test and personalized consultations with a physician and dietitian
  • The test is powered by the latest DNA sequencing techniques, unavailable anywhere else in the UAE
  • The approach is highly individualized, taking into consideration each person's unique microbiome composition and health goals

M42, the global tech-enabled health powerhouse based in Abu Dhabi, is set to revolutionize gut health with the launch of the M42 Microbiome Wellness Program. This groundbreaking initiative, available exclusively at M42, combines advanced DNA sequencing technology with personalized consultations to set new standards for well-being. The program is available at Mubadala Health Dubai, emphasizing M42's commitment to redefining health and wellness globally. It is set to be launched at other M42 assets such as Healthpoint in the future.

Dr. Pranab Gyawali, Consultant Gastroenterologist at Mubadala Health Dubai

Dr. Pranab Gyawali, Consultant Gastroenterologist at Mubadala Health Dubai, believes that optimizing the microbiome is a transformative path to overall health. Recent advancements in DNA technology and AI have paved the way for a unique microbiome test using cutting-edge sequencing techniques. This test generates a comprehensive 60-page report, providing valuable insights for personalized recommendations by healthcare professionals.

Describing the microbiome, Dr. Gyawali said: “It's truly a new, exciting frontier that not many people are aware of. In a nutshell, the microbiome comprises the diverse community of bacteria, viruses and fungi residing within the intestine. These microorganisms, along with the metabolites they produce, play a crucial role in various bodily functions such as immunity, digestion and brain functioning. We now recognize the significance of these products in contributing to and enhancing the overall well-being of the body.”

The exclusive program, featuring the advanced shotgun metagenomic sequencing technology provides quick turnaround times and is licensed by the Ministry of Health and Prevention. It offers tailored solutions for diverse health goals, from addressing gut issues to enhancing sports performance, weight management and diabetes management.

Dr. Gyawali focuses on improving the quality of life for irritable bowel syndrome (IBS) patients through personalized dietary advice. Beyond digestion and immunity, ongoing research explores links between the microbiome and conditions like autoimmune diseases and neurodegenerative disorders.

The program holds potential in sports performance by targeting specific gut bacteria that enhance athletic abilities through lactic acid metabolism and muscle recovery promotion.

For further information on Mubadala Health Dubai, please visit: